Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®

NCT04905667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: GB221
DRUG: Herceptin

Sponsor

Genor Biopharma Co., Ltd.